The fixation system is used for conditions including degenerative sacroiliitis and sacroiliac joint disruption. It has a 3D-printed screw that’s offered in three diameters. The system has ChoiceSpine’s proprietary BioBond technology.
“The addition of the Triton screw to our spinal fusion portfolio delivers on ChoiceSpine’s commitment to provide an innovative, superior system to the sacroiliac fixation market,” Keith Clements, vice president of sales, said in a news release.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
